v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 53,302 $ 72,256
Restricted cash 855 154
Short-term deposits 10,390 10,003
Related party 50
Other current assets 755 2,068
Total current assets 65,302 84,531
Non-current assets    
Lease deposit 5
Property and equipment, net 2,062 1,881
In-process research and development (“R&D”), net 3,419 4,556
Operating lease right-of-use assets 4,370 1,148
Total non-current assets 9,851 7,590
Total asset 75,153 92,121
Current liabilities    
Trade account payables 1,301 3,253
Other account payables 2,814 2,596
Current portion of lease liabilities 594 375
Total current liabilities 4,709 6,224
Non-current liabilities    
Lease liabilities - net of current portion 3,905 856
Contingent liabilities 701 585
Total non-current liabilities 4,606 1,441
Commitments and Contingent Liabilities
Shareholders’ equity    
Common stock, $0.0001 par value (“Common Stock”); Authorized - 60,000,000 shares as of September 30, 2020 and December 31, 2019. Issued - 23,173,378 as of September 30, 2020 and 22,862,835 as of December 31, 2019. Outstanding - 23,167,678 shares as of September 30, 2020 and 22,862,835 as of December 31, 2019 2 2
Additional paid in capital 128,950 126,626
Accumulated deficit (63,114) (42,172)
Total shareholders’ equity 65,838 84,456
Total liabilities and shareholders' equity $ 75,153 $ 92,121

Source